Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

State Medicaid Coverage for Tobacco-Dependence Treatments—United States, 2009

This page is archived for historical purposes and is no longer being updated.

October 22, 2010 / Vol. 59 / No. 41

MMWR Highlights

Pharmacotherapy Coverage by State Medicaid Programs in 2009

  • 47 programs covered at least one tobacco-dependence treatment for some Medicaid enrollees.
  • 38 programs covered some form of pharmacotherapy for all Medicaid enrollees—
    • 34 covered the nicotine patch.
    • 33 covered bupropion or Zyban.®
    • 32 covered nicotine gum.
    • 32 covered varenicline or Chantix.®
    • 28 covered nicotine nasal spray.
    • 27 covered nicotine inhalers.
    • 25 covered nicotine lozenges.
  • 4 programs offered no coverage for tobacco-dependence treatment to their enrollees (i.e., Connecticut, Georgia, Missouri, and Tennessee).
  • The most commonly covered combination of tobacco-dependence treatments were—
    • Nicotine patch and bupropion SR (33 programs).
    • Nicotine patch and gum (21 programs).
    • Nicotine patch and inhaler (21 programs).
    • Nicotine patch and nasal spray (19 programs).

Counseling Coverage by State Medicaid Programs in 2009

  • Medicaid programs covered counseling less often than pharmacotherapy.
  • Medicaid coverage of individual counseling varied across programs.
    • 18 programs covered all Medicaid enrollees.
    • 6 programs covered FFS enrollees (with 2 restricting coverage to pregnant women only.
    • 1 program covered MCO enrollees.
    • 6 programs covered pregnant women only.
  • Medicaid programs covered group counseling less often than individual counseling in some cases.
    • 8 programs covered all Medicaid enrollees.
    • 3 program covered FFS enrollees (with 2 restricting coverage to pregnant women only).
    • 2 programs covered MCO enrollees.
    • 5 programs covered pregnant women only.

Combination Coverage by State Medicaid Programs in 2009

  • 5 programs covered all recommended pharmacotherapies and all counseling for all Medicaid enrollees (i.e., Indiana, Massachusetts, Minnesota, Montana, and Pennsylvania).


Varying Access to Treatment

  • Because some states reported different coverage policies for FFS enrollees, MCO enrollees, and pregnant women, Medicaid recipients within a state might have varying degrees of access to tobacco-dependence treatments.


Health Care Reform

  • Recent federal policy is increasing access to smoking cessation treatments.
    • Section 4107 of the Affordable Care Act requires Medicaid programs to cover tobacco-dependence treatments for pregnant women, with no cost-sharing, starting October 1, 2010.
    • Section 4106 of the Affordable Care Act permits Medicaid programs to cover the A and B level recommendations of the U.S. Preventive Services Task Force, including cessation counseling and all FDA-approved tobacco-dependence treatments. States that offer such benefits and adult vaccination benefits, and prohibit cost sharing on these benefits, will receive a one full percentage point increase in the Medicaid federal medical assistance percentage for expenditures on these services, effective January 1, 2013.

Future Implications

  • To increase the impact of the federal legislation, it is important that Medicaid programs inform their enrollees and providers about changes in coverage for tobacco-dependence treatments and offer these treatments without barriers or limitations.
  • Future monitoring of Medicaid programs should include measuring of usage rates of tobacco-dependence treatments and assessing of any existing coverage barriers.